July 8, 2019 Press release - Regulatory Targovax announces encouraging results from part 1 of the ONCOS-102 and Keytruda combination trial in anti-PD1 refractory melanoma
May 23, 2019 Press release - Regulatory Targovax announces median and three-year overall survival for TG01 trial in resected pancreatic cancer
March 15, 2019 Press release - Regulatory Targovax signs clinical collaboration agreement with the Parker Institute for Cancer Immunotherapy and Cancer Research Institute